Dana Farber PLGA
  • Home
  • About
  • Research
  • Team
  • Publications
  • Contact
  • Support
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Featured Publications

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.

October 1, 2015/in Featured, Featured Publications

In this month’s featured publication, Drs. Santagata, Ligon, and Beroukhim and colleagues published a study where they analyzed brain metastases for alterations in their genetic profiles.   In about half of the cases they found different genetic alterations in the brain metastases when compared with the primary tumor site.  This study showed that the genetically different brain metastases were not detected when a patient undergoes a primary tumor biopsy, suggesting that sequencing the primary tumor alone may miss substantial opportunities for targeted therapy.

https://www.danafarberplga.org/wp-content/uploads/2014/04/2.jpg 1429 1302 Tam https://www.danafarberplga.org/wp-content/uploads/2026/07/newlogo14-1030x129.png Tam2015-10-01 12:19:002015-10-01 12:19:00Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.

MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation

September 2, 2015/in Featured, Featured Publications

In September’s featured publication, Dr. Nathalie Agar and colleagues show how mass spectrometry imaging can be used to detect pituitary tumors during surgery.  This technology may allow surgeons to characterize between the tumor and healthy tissue border in 30 minutes or less, and can be applied for near-real-time detection and surgical decision-making.

https://www.danafarberplga.org/wp-content/uploads/2014/04/2.jpg 1429 1302 Tam https://www.danafarberplga.org/wp-content/uploads/2026/07/newlogo14-1030x129.png Tam2015-09-02 12:29:582015-09-02 12:29:58MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation

Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic.

August 3, 2015/in Featured, Featured Publications

In August’s featured publication, Dr. Kieran and his collaborators discuss diffuse intrinsic pontine glioma (DIPG), and the role of epigenetic and genetic mutations within these tumors that will allow the development of novel therapies in the future.

https://www.danafarberplga.org/wp-content/uploads/2014/04/2.jpg 1429 1302 Tam https://www.danafarberplga.org/wp-content/uploads/2026/07/newlogo14-1030x129.png Tam2015-08-03 15:17:412015-08-03 15:36:34Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic.

Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors.

June 1, 2015/in Featured, Featured Publications

In this month’s featured publication, Dr. Kieran discusses pediatric brain stem gliomas, and how new biological discoveries may lead to potential treatments for these devastating tumors.

https://www.danafarberplga.org/wp-content/uploads/2014/04/2.jpg 1429 1302 Tam https://www.danafarberplga.org/wp-content/uploads/2026/07/newlogo14-1030x129.png Tam2015-06-01 09:00:532015-05-28 12:49:19Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors.

Molecular typing of Meningiomas by Desorption Electrospray Ionization Mass Spectrometry Imaging for Surgical Decision-Making

May 1, 2015/in Featured, Featured Publications

In May’s featured publication, Dr. Agar and colleagues developed tools using mass spectrometry to be used to characterize meningioma tumor from healthy brain tissue during surgery.  These tools could therefore enable surgeons to detect the borders of the tumor better, and remove only the tumor tissue, leaving the healthy brain tissue behind.  These developments could be extended to other brain tumor types in the future, improving surgical procedures.

 

https://www.danafarberplga.org/wp-content/uploads/2014/04/2.jpg 1429 1302 Tam https://www.danafarberplga.org/wp-content/uploads/2026/07/newlogo14-1030x129.png Tam2015-05-01 14:22:032015-05-01 14:22:21Molecular typing of Meningiomas by Desorption Electrospray Ionization Mass Spectrometry Imaging for Surgical Decision-Making

Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype

April 1, 2015/in Featured, Featured Publications

In our April featured publication, investigators from our Program and their collaborators analyzed the gene expression profiles of 151 pediatric low-grade glioma samples.  They discovered significant differences associated with the location of the tumor, the appearance of the tumor and BRAF mutation status.  In particular, supratentorial juvenile pilocytic astrocytomas were enriched with genes involved in inflammation.  These differences in tumor subtypes further our understanding of the role of location in the brain and the microenvironment of the tumor, and may lead to new targets for therapy in the future.

https://www.danafarberplga.org/wp-content/uploads/2014/04/2.jpg 1429 1302 Tam https://www.danafarberplga.org/wp-content/uploads/2026/07/newlogo14-1030x129.png Tam2015-04-01 14:56:412015-04-01 14:56:56Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype

BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma

March 2, 2015/in Featured, Featured Publications

In this month’s featured publication, Dr. Ligon and colleagues investigate the genetic changes that lead to the transformation of pediatric low-grade glioma to secondary high-grade glioma. Using advanced sequencing techniques, they analyzed 886 patient samples and showed there were recurrent alterations in BRAF (to BRAFV600E) and deletion of CDKN2A, amongst other changes in tumors that progressed to high-grade gliomas. The transformation time from low-grade to high-grade glioma occurs over a prolonged period of time, which provides an opportunity for surgical and targeted therapies to mitigate the outcome of secondary high-grade glioma.

https://www.danafarberplga.org/wp-content/uploads/2014/04/2.jpg 1429 1302 Tam https://www.danafarberplga.org/wp-content/uploads/2026/07/newlogo14-1030x129.png Tam2015-03-02 14:35:472015-03-02 14:47:15BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma

Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

December 1, 2014/in Featured, Featured Publications

In this month’s featured publication, researchers in Dr. Gray’s group expand upon previous studies of the FGFR receptor, a protein found mutated in a subset of pilocytic astrocytomas.  However, a common problem in cancer is development of tumor resistance to chemotherapy over time.  Using structure-based drug design, they developed two next-generation covalent inhibitors that can overcome the most common form of resistance, a mutation of the FGFR itself, called the gate-keeeper mutation.  These new inhibitors prevented the actions of FGFR on cultured cells, and will serve as prototype inhibitors that will undergo further preclinical validation.

https://www.danafarberplga.org/wp-content/uploads/2014/04/2.jpg 1429 1302 Tam https://www.danafarberplga.org/wp-content/uploads/2026/07/newlogo14-1030x129.png Tam2014-12-01 14:28:552014-12-01 14:28:55Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

Time to Rethink the Unthinkable: Upfront Biopsy of Children With Newly Diasnosed Diffuse Intrinsic Pontine Glioma (DIPG)

November 3, 2014/in Featured, Featured Publications

In November’s featured publication, Dr. Kieran discusses diffuses intrinsic pontine glioma (DIPG) biopsy.  During the past 50 years, biopsy for these tumors have been discouraged due to excessive toxicity of the procedure.  However, Dana-Farber Cancer Institute and Boston Children’s Hospital have recently opened a multi-site national clinical trial of DIPG biopsy and chemotherapy to change the current dogma and improve treatment outcomes for patients.

https://www.danafarberplga.org/wp-content/uploads/2014/04/2.jpg 1429 1302 Tam https://www.danafarberplga.org/wp-content/uploads/2026/07/newlogo14-1030x129.png Tam2014-11-03 14:07:282014-11-03 14:27:45Time to Rethink the Unthinkable: Upfront Biopsy of Children With Newly Diasnosed Diffuse Intrinsic Pontine Glioma (DIPG)

Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma with Vemurafenib Monotherapy

October 1, 2014/in Featured, Featured Publications

In October’s Featured Publication, Dr. Sandro Santagata treated a patient with BRAF V600E mutated pleomorphic xanthroastrocytoma (PXA), a rare brain tumor in children and young adults. His team used Vemurafenib monotherapy  for the first time in the treatment of V600E-mutated glioma, and saw an encouraging response by the tumor to this approach, leading to the development of a clinical trial for further investigation of BRAF  and MEK inhibitors in combination.

https://www.danafarberplga.org/wp-content/uploads/2014/04/2.jpg 1429 1302 Tam https://www.danafarberplga.org/wp-content/uploads/2026/07/newlogo14-1030x129.png Tam2014-10-01 13:04:482014-10-01 13:04:48Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma with Vemurafenib Monotherapy
Page 2 of 3123

Pages

  • About
  • Contact
  • Home
  • Publications
  • Research
  • Researchers
  • Support
  • Team

Categories

  • Featured
  • Featured Publications
  • News
  • Research
  • Uncategorized

Archive

  • February 2021
  • November 2020
  • May 2020
  • March 2020
  • February 2020
  • October 2019
  • August 2019
  • July 2019
  • June 2019
  • April 2019
  • February 2019
  • January 2019
  • December 2018
  • May 2018
  • December 2016
  • June 2016
  • May 2016
  • April 2016
  • February 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • March 2013
DF PLAG logo
  • Home
  • About
  • Research
  • Team
  • Publications
  • Contact
  • Support
DF PLAG Harvard logo
© Dana Farber PLGA. All rights reserved. Site by Academic Web Pages.
Scroll to top Scroll to top Scroll to top